ArticleBMC veterinary research2026
Inhibitory effects of terpenes on Sarcoptes scabiei in the molting stage.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcoptes scabiei is a permanent ectoparasite causing scabies in humans and sarcoptic mange in animals, resulting in significant health and economic impacts worldwide. Current treatments exhibit limited efficacy against eggs and molting mites, leading to treatment failures. Terpenes from essential oils, including carvacrol, eugenol, and geraniol, have previously shown notable acaricidal and ovicidal activity. In this study, molting Sarcoptes mites were exposed to 0.3% carvacrol, 0.9% eugenol, and 1.1% geraniol for 1 h, resulting in molt rates of 74%, 86%, and 88%, respectively, with carvacrol demonstrating superior efficacy (P < 0.001 vs. control). Further investigation revealed that exposure to 1% carvacrol over varying durations (1 ~ 5 h) achieved complete suppression of molting after 4 h, with a LT50 of 1.4 ± 0.4 h, which is significantly higher than active adult mites(LT50 of 3.45 min in prior research). Microscopic analysis demonstrated intra-corporeal droplets were observed within treated molting mites, which suggest that terpenes likely exert their effects by penetrating the cuticle of molting mites, and carvacrol exhibited greater cuticular penetration efficiency. This study provides foundational evidence for the therapeutic use of carvacrol in managing S. scabiei infestations and highlights the need for further research into its mechanisms of action and safety in veterinary and human applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.